Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Dopamine Receptor D1 Blocking Peptide (AC1338)
Cat.#: ACPP-1338
Specifications
Despition Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1080 GABA B Receptor 2 Blocking Peptide (AC1080) 250 µg inquiry ACPP-1123 Recombinant Rat GFAP Protein (AC1123) 25 µl inquiry ACPP-1589 Human BASP1 Protein (AC1589) 2 µg inquiry ACPP-1797 Human S100A5 Protein (AC1797) 5 µg inquiry ACPP-1805 Human NTS Protein (AC1805) 5 µg inquiry ACPP-1439 Human NHLH1 Protein (AC1439) 1 µg inquiry ACPP-1633 Human PTPS Protein (AC1633) 5 µg inquiry ACPP-1643 Human Transthyretin Protein (AC1643) 5 µg inquiry ACPP-1099 Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) 10 µg inquiry ACPP-1225 POMT1 Blocking Peptide (AC1225) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket